07:00 , Sep 20, 2010 |  BC Week In Review  |  Company News

InSite, SSP Co. Ltd. deal

SSP received exclusive manufacturing and distribution rights in Japan to ISV's AquaSite sustained release dry eye treatment. SSP plans to begin marketing Aquasite in early 2000. InSite Vision Inc. (ISV), Alameda, Calif.   SSP Co....
07:00 , May 22, 2000 |  BC Week In Review  |  Company News

InSite sales and marketing update

ISV partners Global Damon Pharm (Seoul, South Korea) and Kukje Pharma Ind. Co. Ltd. (Seoul) launched in South Korea AquaSite demulcents, which is formulated using ISV's DuraSite drug delivery technology to treat dry eyes. InSite...
07:00 , May 17, 2000 |  BC Extra  |  Company News

InSite Vision launches AquaSite in Korea

Global Damon Pharm and Kukje Pharma launched AquaSite demulcents dry eye treatment in Korea. AquaSite is the first approved product that uses ISV's DuraSite drug delivery technology....
08:00 , Mar 8, 1999 |  BC Week In Review  |  Company News

InSite, Global Damon Pharm sales and marketing update

Damon will exclusively distribute in Korea for 10 years ISV's AquaSite dry eye treatment. Kukje Pharma Ind. Co. Ltd. (Seoul) will manufacture and supply the product to Damon. ISV will receive royalties on net sales....
07:00 , Apr 25, 1994 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

InSite Vision Inc. (INSV) Morgan Stanley analyst Eric Hecht repeated a "buy," saying the recent sell-off in the stock is likely due to hostile market conditions for biotech and large distributions of stock from venture...